EVE Health Group LimitedASX: EVE

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by EVE Health Group Limited via ASX

Filed with ASX ·

31 July 2026 June 2026 Quarterly Update Highlights • Libbo® pilot study progressed , with the final study protocol executed and the contract research organisation and clinical site engaged for EVE's vardenafil oral soluble film for the treatment of erectile dysfunction. • ...

View Attachment

6ix hasn’t read this filing yet.

EVE Health Group Limited on 6ix

Story so far

Earlier from EVE Health

Later from EVE Health

All EVE Health news releases